Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Hold
58
0.01% 733
2026
Q1
$13K Sell
58
-12
-17% -$2.99K 0.01% 597
2025
Q4
$16.9K Buy
70
+68
+3,400% +$17.4K 0.01% 554
2025
Q3
$547 Sell
2
-5
-71% -$1.37K ﹤0.01% 1354
2025
Q2
$1.81K Buy
7
+5
+250% +$1.19K ﹤0.01% 1143
2025
Q1
$448 Hold
2
﹤0.01% 1358
2024
Q4
$457 Buy
+2
New +$482 ﹤0.01% 1354

Other funds holding RMD

WPG Advisers's RMD Position: Q2 2026 in Review

WPG Advisers held its ResMed (RMD) position steady in Q2 2026 at 58 shares worth $11.3K. The position accounts for 0.01% of the portfolio, ranked #733.

WPG Advisers first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.9K in Q4 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • WPG Advisers held 58 shares of ResMed worth $11.3K as of Q2 2026.
  • WPG Advisers left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #733 holding.
  • WPG Advisers first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's ResMed position peaked at $16.9K in Q4 2025.
  • 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.